HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 53 filers reported holding HOMOLOGY MEDICINES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $79,000 | -49.7% | 25,973 | -39.9% | 0.00% | – |
| Q4 2021 | $157,000 | -20.7% | 43,235 | +59.0% | 0.00% | – |
| Q2 2021 | $198,000 | -50.7% | 27,197 | -36.4% | 0.00% | – |
| Q1 2021 | $402,000 | -17.5% | 42,754 | -0.8% | 0.00% | – |
| Q4 2020 | $487,000 | +43.2% | 43,120 | +92.4% | 0.00% | – |
| Q2 2020 | $340,000 | -30.8% | 22,408 | -29.1% | 0.00% | – |
| Q1 2020 | $491,000 | -25.0% | 31,607 | -0.1% | 0.00% | – |
| Q4 2019 | $655,000 | +32.3% | 31,628 | +15.5% | 0.00% | – |
| Q3 2019 | $495,000 | +50.5% | 27,373 | +62.9% | 0.00% | – |
| Q2 2019 | $329,000 | -27.9% | 16,808 | +2.2% | 0.00% | – |
| Q1 2019 | $456,000 | +3.6% | 16,453 | -16.3% | 0.00% | – |
| Q4 2018 | $440,000 | -20.3% | 19,658 | -18.7% | 0.00% | – |
| Q3 2018 | $552,000 | +35.3% | 24,166 | +20.8% | 0.00% | – |
| Q2 2018 | $408,000 | – | 20,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $13,789,000 | 3.01% |
| Vida Ventures Advisors, LLC | 770,845 | $2,343,000 | 1.36% |
| Vivo Capital, LLC | 853,143 | $2,594,000 | 0.18% |
| OUP Management Co., LLC | 64,000 | $195,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $653,000 | 0.13% |
| AAF Wealth Management, LLC | 47,501 | $144,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 228,365 | $694,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $17,179,028 | 0.07% |
| Bellevue Group AG | 1,647,122 | $5,007,000 | 0.06% |
| Virtus ETF Advisers LLC | 35,487 | $108,000 | 0.05% |